Related Experiment Video
Updated: Jan 9, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Pediatric Cancer Survivorship: A Review
Erika Foerst1, Vincent Cendan1, Bhumika Gandhi1,2
1MedStar Georgetown University Hospital, Washington, DC.
Childhood cancer survivors (CCS) face long-term health issues called late effects, requiring lifelong care. Primary care providers need resources to manage these risks, as survivor care often declines over time.
Area of Science:
- Pediatric Oncology
- Survivorship Medicine
- Public Health
Background:
- Childhood cancer survivors (CCS) are susceptible to adverse long-term health outcomes, termed "late effects."
- These effects are individualized, treatment-dependent, and can manifest years after therapy.
- Declining survivor-focused care over time necessitates increased awareness and support.
Purpose of the Study:
- To review key topics for healthcare professionals caring for CCS.
- To highlight the importance of lifelong survivorship care and available resources.
- To emphasize the need for primary care awareness regarding late effects management.
Main Methods:
- Literature review of survivorship care guidelines and research.
- Synthesis of information on organ system-specific late effects.
- Identification of essential components of CCS care, including psychosocial aspects and transitions.
Main Results:
- Late effects encompass physical, psychosocial, functional, and behavioral issues.
- Lifelong screening, prevention, and treatment are crucial for managing late effects.
- Guidelines exist to tailor evaluations based on individual treatment exposures.
Conclusions:
- Primary care providers play a vital role in managing CCS late effects.
- Awareness of resources and guidelines is essential for effective survivorship care.
- Comprehensive care addressing organ-specific issues, psychosocial needs, and transitions is paramount.
Related Concept Videos
Cancer Survival Analysis
Treatment Resistant Cancers
Pharmacokinetics in Pediatric Patients: Drug Excretion
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

